Predicted to enable several functions, including enzyme binding activity; frizzled binding activity; and identical protein binding activity. Involved in positive regulation of neuron projection arborization. Predicted to be located in several cellular components, including aggresome; lateral plasma membrane; and nuclear body. Predicted to be active in cytosol; PARTICIPATES IN Wnt signaling pathway; Wnt signaling, canonical pathway; Wnt signaling, non-canonical pathway; INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; bisphenol A; chlorpyrifos.
[Tetrachlorodibenzodioxin binds to and results in increased activity of AHR protein] which results in increased expression of DVL2 protein modified form
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DVL2 mRNA and AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of DVL2 mRNA]
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of DVL2 mRNA
[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DVL2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DVL2 mRNA
[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DVL2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DVL2 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of DVL2 mRNA
boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in decreased expression of DVL2 mRNA]
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of DVL2 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of DVL2 mRNA
Niclosamide inhibits the reaction [Thioacetamide results in increased expression of DVL2 mRNA] and Poloxamer promotes the reaction [Niclosamide inhibits the reaction [Thioacetamide results in increased expression of DVL2 mRNA]]
WNT1 protein inhibits the reaction [Paraquat results in decreased expression of DVL2 mRNA] and WNT1 protein inhibits the reaction [Paraquat results in decreased expression of DVL2 protein]
Niclosamide inhibits the reaction [Thioacetamide results in increased expression of DVL2 mRNA] and Poloxamer promotes the reaction [Niclosamide inhibits the reaction [Thioacetamide results in increased expression of DVL2 mRNA]]